IL17A and breast carcinoma: The analysis of plasma without stimulation could not reveal a significant difference in IFN-γ, IL-4, and IL-17A, whereas some other cytokines (such as MIP-1b and IL-6) were found to be predictive markers of lymphedema when comparing breast cancer-related lymphedema and breast cancer without lymphedema.45